Meet Our Leadership Team
Our leaders bring decades of experience in specialty care, generics, and operations. Together, they’re guiding Mallinckrodt-Endo, and building what’s next.
Mallinckrodt-Endo Board of Directors
Mallinckrodt-Endo Leadership
Par Health Planned Leadership Team
Par Health will operate as a segment of the merged company until the generics and sterile injectables business spin-off, which is expected to occur at a later date. Stephen Welch will then become President and CEO of the new standalone company.